Literature DB >> 24303938

Distribution of rat neonatal Fc receptor in the principal organs of neonatal and pubertal rats.

Zehua Tian1, Brian J Sutton, Xiaoying Zhang.   

Abstract

The neonatal Fc receptor (FcRn) mediates the transfer of IgG and albumin, also protects them from catabolism. This study characterized the expression of FcRn in different organs of neonatal and pubertal rats by reverse transcription-PCR (RT-PCR) and immunohistochemistry, demonstrates that FcRn is expressed in liver, kidney, intestine, heart, lung, spleen, skin and skeletal muscles at varying levels post-gestation from d 1 to d 63. This finding is contrary to previous studies claiming that FcRn is undetectable in most tissues after weaning. Lungs were the predominant organs for FcRn expression, whereas skin, liver and intestine are considerably less expressed organs. The expression of FcRn fluctuated in all the organs tested, and with a higher frequency before weaning compared to puberty. These findings may provide clues for the better understanding of FcRn function, and are important for determining the dosage levels for IgG and the constant region fragment (Fc)-containing therapeutic proteins whose half-life is regulated by FcRn.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24303938     DOI: 10.3109/10799893.2013.865745

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

Review 1.  Opportunities and Challenges for PBPK Model of mAbs in Paediatrics and Pregnancy.

Authors:  Katherine L Gill; Hannah M Jones
Journal:  AAPS J       Date:  2022-06-01       Impact factor: 3.603

2.  Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies.

Authors:  Paul R V Malik; Abdullah Hamadeh; Andrea N Edginton
Journal:  Pharm Res       Date:  2022-02-03       Impact factor: 4.200

3.  TGEV infection up-regulates FcRn expression via activation of NF-κB signaling.

Authors:  Jinyue Guo; Fei Li; Shaoju Qian; Dingren Bi; Qigai He; Hui Jin; Rui Luo; Shaowen Li; Xianrong Meng; Zili Li
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

4.  Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim.

Authors:  Sumit Basu; Yi Ting Kayla Lien; Valvanera Vozmediano; Jan-Frederik Schlender; Thomas Eissing; Stephan Schmidt; Christoph Niederalt
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

Review 5.  Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients.

Authors:  Zaid H Temrikar; Satyendra Suryawanshi; Bernd Meibohm
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

6.  Knowledge Gaps in the Pharmacokinetics of Therapeutic Proteins in Pediatric Patients.

Authors:  Bernd Meibohm
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

Review 7.  Molecular Mechanisms of Acute Organophosphate Nephrotoxicity.

Authors:  Vladislav E Sobolev; Margarita O Sokolova; Richard O Jenkins; Nikolay V Goncharov
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

8.  A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab.

Authors:  Hsuan Ping Chang; Valentina Shakhnovich; Adam Frymoyer; Ryan Sol Funk; Mara L Becker; K T Park; Dhaval K Shah
Journal:  Br J Clin Pharmacol       Date:  2021-07-19       Impact factor: 3.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.